Geron Forms Collaboration with Boehringer Mannheim to Develop and Commercialize New Class of Cancer Diagnostics; Agreement Focuses on Advances in Telomerase Detection Technologies.
Business Wire › December 22, 1997
Linked as:
Extract
Geron Forms Collaboration with Boehringer Mannheim to Develop and Commercialize New Class of Cancer Diagnostics; Agreement Focuses on Advances in Telomerase Detection Technologies.
MENLO PARK, Calif.--(BW HealthWire)--Dec. 22, 1997--Geron Corp. (NASDAQ:GERN) announced today that it has formed a worldwide collaboration with Boehringer Mannheim, GmbH to develop and commercialize res...
See the full content of this document
Sponsored links
